Cargando…
Preventing Alzheimer's disease within reach by 2025: Targeted‐risk‐AD‐prevention (TRAP) strategy
INTRODUCTION: Alzheimer's disease (AD) is a progressive neurodegenerative disease that currently affects 6.2 million people in the United States and is projected to impact 12.7 million worldwide in 2050 with no effective disease‐modifying therapeutic or cure. In 2011 as part of the National Alz...
Autores principales: | Vitali, Francesca, Branigan, Gregory L., Brinton, Roberta Diaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451031/ https://www.ncbi.nlm.nih.gov/pubmed/34584937 http://dx.doi.org/10.1002/trc2.12190 |
Ejemplares similares
-
Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020) -
Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score matched type 2 diabetics
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Detect–Treat–Prevent–Build: Strategy for TB Elimination in India by 2025
por: Purty, Anil Jacob
Publicado: (2018) -
Androgen‐targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer
por: Branigan, Gregory L., et al.
Publicado: (2022) -
Dietary sodium reduction in Canada: more action is needed to reach the 2025 global targets
por: Arcand, JoAnne, et al.
Publicado: (2022)